
Midatech Pharma plc MTP
Annual report 2025
added 04-25-2026
Midatech Pharma plc DPO Ratio 2011-2026 | MTP
Annual DPO Ratio Midatech Pharma plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 162 | 11.9 K | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.9 K | 162 | 6.04 K |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
193 | $ 0.83 | -0.96 % | $ 37.9 M | ||
|
Exelixis
EXEL
|
148 | $ 46.83 | -3.85 % | $ 12.7 B | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Fortress Biotech
FBIO
|
400 | $ 2.48 | -2.94 % | $ 69.2 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
75.2 | $ 22.17 | 3.19 % | $ 3.67 B | ||
|
Advaxis
ADXS
|
143 K | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.14 | -0.32 % | $ 653 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 22.41 | -7.3 % | $ 2.85 B | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.63 | -4.41 % | $ 434 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Завод ДИОД
DIOD
|
30.3 | - | - | - | ||
|
Фармсинтез
LIFE
|
306 | - | - | - |